Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v2-FR
Language French French
Date Updated 2020-02-13 2017-03-13
Drug Identification Number 01930680 01930680
Brand name PENICILLIN G SODIUM FOR INJECTION, USP PENICILLIN G SODIUM FOR INJECTION, USP
Common or Proper name PENICILLIN G SODIUM PENICILLIN G SODIUM
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients PENICILLIN G SODIUM PENICILLIN G SODIUM
Strength(s) 10000000UNIT 10000000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 10
ATC code J01CE J01CE
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-01-25 2016-01-25
Estimated end date 2022-12-31 2017-06-01
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments